Author Search Results

1

Targeting Resident Memory T Cells for Cancer Immunotherapy

by Charlotte Blanc, Sophie Hans, Thi Tran, Clemence Granier, Antonin Saldman, Marie Anson, Stephane Oudard, Stephane Oudard, Eric Tartour, Eric Tartour
Published 2018-07-01

Get full text

Article

2

Precision immunity: Immunoscore and neoadjuvant treatment in bladder cancer

by Elise F. Nassif, Constance Thibault, Stéphane Oudard, Jérôme Galon
Published 2021-01-01

Get full text

Article

3

Enhance the Immune Checkpoint Inhibitors Efficacy with Radiotherapy Induced Immunogenic Cell Death: A Comprehensive Review and Latest Developments

by Adrien Procureur, Audrey Simonaggio, Jean-Emmanuel Bibault, Stéphane Oudard, Yann-Alexandre Vano
Published 2021-02-01

Get full text

Article

4

Tumor Microenvironment Features as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors (ICI) in Metastatic Clear Cell Renal Cell Carcinoma (mccRCC)

by Audrey Simonaggio, Nicolas Epaillard, Cédric Pobel, Marco Moreira, Stéphane Oudard, Yann-Alexandre Vano
Published 2021-01-01

Get full text

Article

5

Comparative Efficacy of First-Line Immune-Based Combination Therapies in Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-Analysis

by Reza Elaidi, Letuan Phan, Delphine Borchiellini, Philippe Barthelemy, Alain Ravaud, Stéphane Oudard, Yann Vano
Published 2020-06-01

Get full text

Article

6

Is There Still Room for Cancer Vaccines at the Era of Checkpoint Inhibitors

by Soumaya Karaki, Marie Anson, Thi Tran, Delphine Giusti, Charlotte Blanc, Stephane Oudard, Eric Tartour
Published 2016-11-01

Get full text

Article

7

SORAFENIB FOR OLDER PATIENTS WITH RENAL CELL CARCINOMA: SUBSET ANALYSIS FROM A RANDOMIZED TRIAL

by T. Eisen, S. Oudard, C. Szczylik, G. Gravis, H. Heinzer, R. Middleton, F. Cihon, S. Anderson, S. Shah, R. Bukowski
Published 2014-08-01

Get full text

Article

8

SORAFENIB FOR OLDER PATIENTS WITH RENAL CELL CARCINOMA: SUBSET ANALYSIS FROM A RANDOMIZED TRIAL

by T. Eisen, S. Oudard, C. Szczylik, G. Gravis, H. Heinzer, R. Middleton, F. Cihon, S. Anderson, S. Shah, R. Bukowski
Published 2014-08-01

Get full text

Article

9

Correction to: Pericardial effusion under nivolumab: case-reports and review of the literature

by Anastasia Saade, Audrey Mansuet-Lupo, Jennifer Arrondeau, Constance Thibault, Mariana Mirabel, François Goldwasser, Stéphane Oudard, Laurence Weiss
Published 2019-12-01

Get full text

Article

10

Pericardial effusion under nivolumab: case-reports and review of the literature

by Saade Anastasia, Mansuet-Lupo Audrey, Arrondeau Jennifer, Thibault Constance, Mirabel Mariana, Goldwasser François, Oudard Stéphane, Weiss Laurence
Published 2019-10-01

Get full text

Article

11

Optimal cut-off for neutrophil-to-lymphocyte ratio: Fact or Fantasy? A prospective cohort study in metastatic cancer patients.

by Yann-Alexandre Vano, Stéphane Oudard, Marie-Agnès By, Pauline Têtu, Constance Thibault, Hail Aboudagga, Florian Scotté, Reza Elaidi
Published 2018-01-01

Get full text

Article

12

THE SIDE EFFECTS OF SORAFENIB, SUNITINIB, AND TEMSIROLIMUS AND THEIR THERAPY IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA

by N. Bhojani, C. Jeldres, J.-J. Patard, P. Perrotte, N. Suardi, G. Hutterer, F. Patenaude, S. Oudard, P. I. Karakiewicz
Published 2014-08-01

Get full text

Article

13

THE SIDE EFFECTS OF SORAFENIB, SUNITINIB, AND TEMSIROLIMUS AND THEIR THERAPY IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA

by N. Bhojani, C. Jeldres, J.-J. Patard, P. Perrotte, N. Suardi, G. Hutterer, F. Patenaude, S. Oudard, P. I. Karakiewicz
Published 2014-08-01

Get full text

Article

14

Cloud thermodynamic phase inferred from merged POLDER and MODIS data

by J. Riedi, B. Marchant, S. Platnick, B. A. Baum, F. Thieuleux, C. Oudard, F. Parol, J.-M. Nicolas, P. Dubuisson
Published 2010-12-01

Get full text

Article

15

Pain Progression at Initiation of Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Post Hoc Analysis of the PROSELICA Study

by Nicolas Delanoy, Debbie Robbrecht, Mario Eisenberger, Oliver Sartor, Ronald de Wit, Florence Mercier, Christine Geffriaud-Ricouard, Johann de Bono, Stéphane Oudard
Published 2021-03-01

Get full text

Article

16

Immune-related adverse events: a retrospective look into the future of oncology in the intensive care unit

by Adrien Joseph, Audrey Simonaggio, Annabelle Stoclin, Antoine Vieillard-Baron, Guillaume Geri, Stéphane Oudard, Jean-Marie Michot, Olivier Lambotte, Elie Azoulay, Virginie Lemiale
Published 2020-10-01

Get full text

Article

17

High milk consumption does not affect prostate tumor progression in two mouse models of benign and neoplastic lesions.

by Sophie Bernichtein, Natascha Pigat, Thierry Capiod, Florence Boutillon, Virginie Verkarre, Philippe Camparo, Mélanie Viltard, Arnaud Méjean, Stéphane Oudard, Jean-Claude Souberbielle, Gérard Friedlander, Vincent Goffin
Published 2015-01-01

Get full text

Article

18

Risk of hormone escape in a human prostate cancer model depends on therapy modalities and can be reduced by tyrosine kinase inhibitors.

by Charlotte Guyader, Jocelyn Céraline, Eléonore Gravier, Aurélie Morin, Sandrine Michel, Eva Erdmann, Gonzague de Pinieux, Florence Cabon, Jean-Pierre Bergerat, Marie-France Poupon, Stéphane Oudard
Published 2012-01-01

Get full text

Article

19

Cabazitaxel multiple rechallenges in metastatic castration‐resistant prostate cancer

by Cedric Pobel, Edouard Auclin, Diego Teyssonneau, Brigitte Laguerre, Mathilde Cancel, Elouen Boughalem, Johanna Noel, Pierre Emmanuel Brachet, Denis Maillet, Philippe Barthelemy, Carole Helissey, Constance Thibault, Stéphane Oudard
Published 2021-09-01

Get full text

Article

20

A phase III, randomized, open-label study (CONTACT-02) of cabozantinib plus atezolizumab versus second novel hormone therapy in patients with metastatic castration-resistant prosta...

by Agarwal, N., Azad, A., Benzaghou, F., Carles, J., Chowdhury, S., Kerloeguen, Y., Kimura, A., Mcgregor, B., Merseburger, A.S, Mohamed, N., Oudard, S., Pal, S., Panneerselvam, A., Saad, F., Soares, A., Wang, F.
Published 2022

View Fulltext in Publisher

Article

Related Subjects